First Key Update of the International AI Safety Report released
MONTREAL, Oct. 15, 2025 /PRNewswire/ -- The first Key Update of the International AI Safety Report has been published, providing a timely update on the capabilities and risks of advanced AI. Chaired by Turing Award-winning computer scientist Yoshua Bengio, the Report involves more than 100 international experts and is backed by over 30 countries and international organisations including the EU, OECD...
Tamarind Health Marks Next Phase as Asia’s Leading Integrated Oncology Platform
SINGAPORE, Oct. 15, 2025 /PRNewswire/ -- Tamarind Health marks the next phase in its growth as Asia's leading integrated oncology-focused healthcare platform, following the completion of its acquisition of TalkMED in September 2025. A doctor-led platform built on the principle of putting patients first, Tamarind Health brings together leading medical practices across the region...
Sinocare Showcases Its Comprehensive Diabetes Management Solutions at EASD
VIENNA, Oct. 15, 2025 /PRNewswire/ -- The 61st Annual Meeting of the European Association for the Study of Diabetes (EASD 2025) was successfully held in Vienna, Austria. During the conference, Sinocare hosted an international industry symposium and an exclusive networking dinner, fully demonstrating the company's professional expertise in diabetes management. International...
Safex Chemicals India Ltd. Receives Frost & Sullivan’s 2025 Global Competitive Strategy Leadership Recognition for Excellence in Crop Protection Chemicals
Safex earns global recognition for its innovation-driven strategy, digital transformation, and customer-centric approach in the evolving crop protection chemicals industry. SAN ANTONIO, Oct. 15, 2025 /PRNewswire/ -- Frost & Sullivan is pleased to announce that Safex Chemicals India Ltd. (Safex) has been recognized with the 2025 Global Competitive Strategy Leadership Recognition in the crop protection chemicals industry for its outstanding achievements in...
At the World Congress of Neurology, WHO Outlines a Global Roadmap to Make Brain Health a Universal Reality
SEOUL, South Korea and LONDON, Oct. 15, 2025 /PRNewswire/ -- Neurological conditions now affect more than 40% of the population—over 3 billion people, according to WHO's Global Status Report on Neurology, released at the World Congress of Neurology (WCN) in Seoul. The report reveals that neurological conditions affect one in three people, with over 80% of the burden in...
Connect With ASEAN : Quality Choice Cremo Crush
BEIJING, Oct. 13, 2025 /PRNewswire/ -- A report by China Report ASEAN On September 29, the Asia-Pacific Center of the China International Communications Group (CICG) released the episode of its "Connect With ASEAN", titled "Quality Choice, Cremo Crush."  Quality Choice, Cremo Crush https://www.youtube.com/watch?v=ZqbsRQIALU0 In 2018, Yili Group Thailand started operated Cremo Ice Cream, officially entering...
Nona Biosciences Appoints Dr. Di Hong as Chief Executive Officer to Drive Technology Innovation and Strategic Growth
CAMBRIDGE, Mass., Oct. 15, 2025 /PRNewswire/ -- Nona Biosciences ("Nona" or the "Company"), a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), today announced the appointment of Dr. Di Hong as Chief Executive Officer (CEO). Dr. Hong will be based in Shanghai and report directly to Dr....
Mabwell Announces Latest Clinical Results of Novel B7-H3-Targeting ADC 7MW3711 to Be Presented at 2025 ESMO Congress
SHANGHAI, Oct. 15, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that clinical research results of its novel B7-H3-targeting ADC (R&D code: 7MW3711) for multiple advanced solid tumors, will be presented as a poster at the European Society for Medical Oncology (ESMO) Congress 2025. As of Sep. 15, 2025, 74 patients with advanced...
Benchling Reveals the Next Chapter of R&D at Benchtalk 2025
Benchling AI debuts alongside major new capabilities for antibody discovery, automated data analysis, and development BOSTON, Oct. 14, 2025 /PRNewswire/ -- Benchling today unveiled major new capabilities at Benchtalk, its annual customer conference. These new releases are designed to help biotech companies automate R&D workflows and bring the power of AI into...
Co-PSMA trial achieves primary endpoint
SYDNEY, Oct. 14, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that the Co-PSMA (NCT06907641) Investigator-Initiated Trial (IIT), led by Prof Louise Emmett at St Vincent's Hospital...
